Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Raffles Medical Group Ltd (BSL.SI)
Singapore, SG
Raffles Medical Group Ltd (RMG), a prominent Singapore-headquartered company, delivers integrated private healthcare services across Singapore, Greater China, Vietnam, Cambodia, and Japan. Its operations are structured into Healthcare Services, Hospital Services, and Investment Holdings segments. The group's flagship institution, Raffles Hospital, functions as a tertiary care facility, offering a broad spectrum of medical services. These include oncology, pediatrics and women's health, traditional Chinese medicine, counseling, dental care, dialysis, diabetes and endocrinology, ENT, ophthalmology, fertility treatments, cardiology, internal medicine, neuroscience, pain management, rehabilitation, orthopedics, dermatological and aesthetic services, general surgery, nuclear medicine, and urology. Beyond the hospital, RMG provides emergency services, family medicine, comprehensive health screening, and a variety of multi-disciplinary specialist clinic services. Additionally, the company engages in the trade of pharmaceutical and nutraceutical products, and diagnostic equipment. It also offers advisory and consultancy services, develops IT solutions, and undertakes research and experimental development in biotechnology, life sciences, and medical science. The company was founded in 1976.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +2.12% | +1.05% | -3.02% | -8.96% | -2.53% | -5.39% | -2.53% | -27.44% | -15.35% | -37.74% | +436.11% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 1 | 0 |
| Buy | 5 | 0 |
| Hold | 1 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Medical - Care Facilities: +10.2%+1.8% Q2'25: +3.5% (vs Q2'24)
-
EPS growth Medical - Care Facilities: +19.2%+14.1% Q2'25: +6.2% (vs Q2'24)
-
FCF margin FCF growth · Medical - Care Facilities: +32.0%+11.2% ★ Q2'25: +14.2% (vs Q2'24)
-
EBIT margin Medical - Care Facilities: +11.3%+11.4% ★ Q2'25: +11.0% (vs Q2'24)
-
ROIC Medical - Care Facilities: +6.8%+7.8% ★ Q2'25: +7.4% (vs Q2'24)
-
Share dilution Medical - Care Facilities: +0.0%-0.4% ★ Q2'25: -1.6% (vs Q2'24)
-
Debt / EBITDA Net debt/EBITDA · Medical - Care Facilities: 0.99×0.88× ★ Q2'25: 0.70× (vs Q2'24)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2015 actual |
Dec 2016 actual |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 7 Rev. Ana. 6 EPS Ana. |
Dec 2027 7 Rev. Ana. 6 EPS Ana. |
Dec 2028 5 Rev. Ana. 4 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
410.54M
est: 407.96M (+0.6%)
|
473.61M
est: 476.80M (-0.7%)
|
477.58M
est: 481.30M (-0.8%)
|
489.14M
est: 497.38M (-1.7%)
|
522.04M
est: 532.15M (-1.9%)
|
568.20M
est: 534.34M (+6.3%)
|
723.79M
est: 705.85M (+2.5%)
|
822.92M
est: 782.07M (+5.2%)
|
708.03M
est: 702.97M (+0.7%)
|
751.56M
est: 752.25M (-0.1%)
|
765.30M
est: 789.65M (-3.1%)
|
795.30M
778.02M – 813.98M
+0.7% YoY
|
831.29M
791.45M – 870.95M
+4.5% YoY
|
869.02M
868.32M – 869.72M
+4.5% YoY
|
| EBITDA |
94.51M
est: 89.32M (+5.8%)
|
97.75M
est: 104.40M (-6.4%)
|
96.01M
est: 105.38M (-8.9%)
|
103.59M
est: 108.90M (-4.9%)
|
107.13M
est: 116.52M (-8.1%)
|
125.09M
est: 117.00M (+6.9%)
|
161.27M
est: 154.55M (+4.3%)
|
235.87M
est: 171.24M (+37.7%)
|
132.89M
est: 146.97M (-9.6%)
|
133.40M
est: 157.27M (-15.2%)
|
130.65M
est: 165.09M (-20.9%)
|
166.27M
162.66M – 170.18M
+0.7% YoY
|
173.79M
165.47M – 182.09M
+4.5% YoY
|
181.68M
181.54M – 181.83M
+4.5% YoY
|
| EBIT |
81.70M
est: 68.52M (+19.2%)
|
83.08M
est: 80.08M (+3.7%)
|
81.02M
est: 80.84M (+0.2%)
|
85.32M
est: 83.54M (+2.1%)
|
77.87M
est: 89.38M (-12.9%)
|
89.59M
est: 89.75M (-0.2%)
|
121.94M
est: 118.55M (+2.9%)
|
196.74M
est: 131.35M (+49.8%)
|
108.18M
est: 111.93M (-3.4%)
|
91.52M
est: 119.78M (-23.6%)
|
87.26M
est: 125.73M (-30.6%)
|
126.63M
123.88M – 129.61M
+0.7% YoY
|
132.36M
126.02M – 138.68M
+4.5% YoY
|
138.37M
138.26M – 138.48M
+4.5% YoY
|
| Net Income |
69.29M
est: 75.28M (-8.0%)
|
70.21M
est: 76.17M (-7.8%)
|
70.78M
est: 72.93M (-2.9%)
|
71.06M
est: 70.57M (+0.7%)
|
60.27M
est: 59.16M (+1.9%)
|
65.89M
est: 56.85M (+15.9%)
|
84.17M
est: 77.14M (+9.1%)
|
143.21M
est: 122.34M (+17.1%)
|
90.15M
est: 60.94M (+47.9%)
|
62.24M
est: 63.71M (-2.3%)
|
70.57M
est: 70.57M (+0.0%)
|
72.82M
69.90M – 74.16M
+3.2% YoY
|
78.73M
73.42M – 92.70M
+8.1% YoY
|
88.37M
84.87M – 94.30M
+12.2% YoY
|
| SGA |
35.77M
est: 36.98M (-3.3%)
|
46.99M
est: 43.21M (+8.7%)
|
44.83M
est: 43.62M (+2.8%)
|
46.70M
est: 45.08M (+3.6%)
|
41.16M
est: 48.23M (-14.7%)
|
38.74M
est: 48.43M (-20.0%)
|
41.65M
est: 63.98M (-34.9%)
|
103.92M
est: 70.88M (+46.6%)
|
142.44M
est: 63.46M (+124.5%)
|
—
est: 67.90M (-100.0%)
|
50.78M
est: 71.28M (-28.8%)
|
71.79M
70.23M – 73.48M
+0.7% YoY
|
75.04M
71.44M – 78.62M
+4.5% YoY
|
78.45M
78.38M – 78.51M
+4.5% YoY
|
| EPS |
0.04
est: 0.04 (+0.1%)
|
0.04
est: 0.04 (-1.3%)
|
0.04
est: 0.04 (+2.6%)
|
0.04
est: 0.04 (+4.9%)
|
0.03
est: 0.03 (+4.4%)
|
0.04
est: 0.03 (+17.2%)
|
0.05
est: 0.04 (+8.8%)
|
0.08
est: 0.07 (+17.0%)
|
0.05
est: 0.03 (+47.9%)
|
0.03
est: 0.03 (+0.0%)
|
0.04
est: 0.04 (-1.2%)
|
0.04
0.04 – 0.04
+2.3% YoY
|
0.04
0.04 – 0.05
+7.7% YoY
|
0.05
0.05 – 0.05
+11.2% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-28 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-26 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-25 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-22 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-21 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-20 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-19 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-18 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-15 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-14 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-13 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-12 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-11 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-08 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-07 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-06 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-05 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-04 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 3/5 | 1/5 | 1/5 |
| 2026-04-30 | C | 2/5 | 5/5 | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-29 | C | 2/5 | 5/5 | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-28 | C | 2/5 | 5/5 | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-27 | C | 2/5 | 5/5 | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-24 | C | 2/5 | 5/5 | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-23 | C | 2/5 | 5/5 | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-22 | C | 2/5 | 5/5 | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-21 | C | 2/5 | 5/5 | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-20 | C | 2/5 | 5/5 | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-17 | C | 2/5 | 5/5 | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-16 | C | 2/5 | 5/5 | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | Xtrackers MSCI Singapore UCITS ETF 1C O9A.SI | 0.11% | 132.3K | 0.50% |
| 2 | iShares MSCI AC Far East ex-Japan Small Cap UCITS ETF ISFE.L | 0.05% | 39.0K | 0.74% |
| 3 | Avantis International Small Cap Equity ETF AVDS | 0.05% | 166.7K | 0.30% |
| 4 | State Street SPDR S&P International Small Cap ETF GWX | 0.05% | 442.9K | 0.40% |
| 5 | Schwab International Small-Cap Equity ETF SCHC | 0.02% | 1.21M | 0.06% |
| 6 | UBS MSCI World Small Cap Socially Responsible UCITS ETF USD dis WSCR.L | 0.02% | 155.1K | 0.23% |
| 7 | UBS MSCI World Small Cap Socially Responsible UCITS ETF USD acc WSCSRI.SW | 0.02% | 155.2K | 0.23% |
| 8 | iShares Currency Hedged MSCI EAFE Small-Cap ETF HSCZ | 0.02% | 35.7K | 0.83% |
| 9 | iShares MSCI EAFE Small-Cap ETF SCZ | 0.02% | 2.15M | 0.40% |
| 10 | Vanguard FTSE All-World ex-US Small-Cap ETF VSS | 0.01% | 1.94M | 0.06% |
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Choon Yong Loo | Executive Chairman & Chief Executive Officer | 8M | — |
| Qinghui Lu | Co-MD of Singapore Healthcare Div., Executive Medical Director & Executive Non Independent Director | 611.2K | — |
| Kenneth Wu | Co-MD of Singapore Healthcare Division | — | — |
| Kimmy Goh | Company Secretary & Group Financial Controller | — | female |
| Joanna Lee | Senior Manager of Communications | — | female |
| Tanie Eio | Chief Human Resources Officer | — | female |
| Terence Foo | Chief Technology Officer | — | male |
| Yeng Yeng Woo | Chief Financial Officer | — | female |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for BSL.SI
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
